SCHEMBL7111815

SCHEMBL7111815

CNC(=S)NS(=O)(=O)c1cc(CCNC(=O)C=C(c2ccccc2)c2ccccc2)ccc1OC

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ABCC9 O60706 1/20 0.61
ABCC8 Q09428 1/20 0.61
KCNJ11 Q14654 1/20 0.61
ALDH1A1 P00352 7/20 0.49
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 2/20 0.49
HPGD P15428 1/20 0.49
ALOX12 P18054 1/20 0.49
MAPT P10636 5/20 0.46
HTT P42858 2/20 0.44
ALOX5 P09917 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7112531 0.92 ABCC9 (0.60) ABCC9ABCC8KCNJ11ALDH1A1KMT2A
SCHEMBL6191744 0.88 ABCC9 (0.66) ABCC9ABCC8KCNJ11ALDH1A1KMT2A
SCHEMBL4264927 0.85 MAPT (0.66) ABCC9ABCC8KCNJ11ALDH1A1KMT2A
SCHEMBL7111310 0.85 MAPT (0.66) ABCC9ABCC8KCNJ11ALDH1A1KMT2A
SCHEMBL7111814 0.84 ABCC9 (0.59) ABCC9ABCC8KCNJ11ALDH1A1KMT2A
SCHEMBL7111813 0.84 ABCC9 (0.59) ABCC9ABCC8KCNJ11ALDH1A1KMT2A
SCHEMBL7110672 0.84 MAPT (0.51) ALDH1A1KMT2ASMN1; SMN2MEN1HPGD
SCHEMBL7112525 0.81 ABCC9 (0.60) ABCC9ABCC8KCNJ11ALDH1A1KMT2A
SCHEMBL7112530 0.81 ABCC9 (0.60) ABCC9ABCC8KCNJ11ALDH1A1KMT2A
SCHEMBL4702222 0.81 ABCC9 (0.58) ABCC9ABCC8KCNJ11ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183236-B1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AVENTIS PHARMA GMBH (DE) 2003-10-22 EP disclosed
EP-1183236-A1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES Aventis Pharma Deutschland GmbH (DE) 2002-03-06 EP disclosed
US-6350778-B1 CARDIOVASCULAR DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-02-26 US disclosed
WO-2000071513-A1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-30 WO disclosed